An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Vaccines, Blood & Biologics

CUTAQUIG

STN #: BLA 125668
Proper Name: Immune Globulin Subcutaneous (Human) -hipp, 16.5%
Tradename: CUTAQUIG
Manufacturer: OCTAPHARMA Pharmazeutika Produktionsges.m.b.H.
Indication:

CUTAQUIG (Immune Globulin Subcutaneous (Human) - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and Pediatric patients 2 years of age and older.

Product Information

Package Insert - CUTAQUIG
Demographic Subgroup Information – Immune Globulin Subcutaneous (Human)
Refer to Section 1.1 of the clinical reviewer memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Related Information

Expiration Date Extension for 43 Cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] Lots manufactured in 2019 and 2020

Top